Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Lisa Fredeau"'
Autor:
Lisa Fredeau, Delphine S. Courvoisier, Raphael Ait Mehdi, Saskia Ingen-Housz-Oro, Emmanuel Mahe, Nathalie Costedoat-Chalumeau, Laurent Arnaud, Camille Francès, Alexis Mathian, Marie Jachiet, Zahir Amoura, Jean David Bouaziz, François Chasset
Publikováno v:
Journal of the American Academy of Dermatology.
No study has assessed the risk factors of progression from discoid lupus erythematosus (DLE) to severe systemic lupus erythematosus (sSLE) (defined as requiring hospitalization and specific treatment).To identify the risks factors of and generate a p
Autor:
Laura Soumoy, Virginie Quidville, Lisa Fredeau, Giuseppina Claps, Caroline Pradon, Ludovic Lacroix, Emilie Routier, Djaouida Belkadi, Séverine Roy, Feras Chehade, Stephan Vagner, Caroline Robert
Publikováno v:
Cancer Research. 83:2177-2177
Introduction: High LDH activity is associated with a poor prognosis in many cancer types, especially in melanoma where it is the strongest indicator of poor outcome even with the most potent anticancer immunotherapies or targeted therapies. Although
Autor:
Pierre-Emmanuel Stoebner, Christophe Bedane, A. Jannic, Marc Dumas, Marie Moncourier, Sandrine Mansard, Anne-Bénédicte Duval-Modeste, David Solub, Sophie Darras, Suzanne Devaux, Julia Sanchez, Nicolas Meyer, Laurent Misery, Valentine Heidelberger, Raoul Triller, Ingrid Kupfer-Bessaguet, Nathalie Beneton, Florence Brunet-Possenti, Gaëlle Quéreux, E. Maubec, Sophie Dalac, François Skowron, Safia Abed, Caroline Gaudy-Marqueste, Laurent Mortier, Monica Dinulescu, F. Herms, Lucie Peuvrel, Marouane Boubaya, Candice Hober, Pierre Guillet, Mahtab Samimi, Yves Reguerre, Nicolas Poulalhon, Anne Pham-Ledard, Stéphanie Catala, Eve-Marie Neidhardt, Romain Lesbazeilles, Jean-Philippe Arnault, Brigitte Dréno, Olivier Collard, Philippe Celerier, Julie De Quatrebarbes, Youssef Tazi, Pierre Combe, Caroline Jacobzone, Élodie Archier, F. Aubin, Dominique Spaeth, Clémence Berthin, Nora Kramkimel, Florent Grange, Candice Lesage, Lisa Fredeau, A. Schoeffler, Marc Pracht, Bertille Bonniaud, Laure Cesaire, Maxime Etienne, Olivier Lauche
Publikováno v:
Cancers
Cancers, 2021, 13 (14), 14 p. ⟨10.3390/cancers13143547⟩
Cancers, Vol 13, Iss 3547, p 3547 (2021)
Cancers, MDPI, 2021, 13 (14), 14 p. ⟨10.3390/cancers13143547⟩
Volume 13
Issue 14
Cancers, 2021, 13 (14), 14 p. ⟨10.3390/cancers13143547⟩
Cancers, Vol 13, Iss 3547, p 3547 (2021)
Cancers, MDPI, 2021, 13 (14), 14 p. ⟨10.3390/cancers13143547⟩
Volume 13
Issue 14
Although cemiplimab has been approved for locally advanced (la) and metastatic (m) cutaneous squamous-cell carcinomas (CSCCs), its real-life value has not yet been demonstrated. An early-access program enrolled patients with la/mCSCCs to receive cemi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc71b63af8c9862b6ab08fc449cfdcd5
https://hal.inrae.fr/hal-03332168
https://hal.inrae.fr/hal-03332168